You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
富祥藥業(300497.SZ)拉昇創逾5年新高 2個月內暴漲124%
格隆匯 09-23 11:24
格隆匯9月23日丨延續近期強勢,富祥藥業(300497.SZ)今日盤中再度拉昇,一度漲近19%至22.95元,股價創2016年8月以來新高,市值突破100億元。該股自7月底啟動上漲行情至今,期間累計最大漲幅達124%。由於股價短期內暴漲,富祥藥業9月16日收到深交所關注函,要求補充披露上海凌富從事的主要業務及具體業務模式,補充説明上海凌富在研產品的知識產權歸屬情況,相關安排是否符合行業慣例;分析公司股價漲幅明顯偏離大盤的原因並説明公司基本面是否發生重大變化,並就公司近期股價漲幅較大進行充分的風險提示。富祥藥業日前回復關注函稱,上海凌富處於初創階段,雖已有部分訂單,但暫未形成正式銷售,收入規模、市場佔有率等暫未顯現,另外,上海凌富業績持續增長的能力,受市場環境的變化、股東融合優勢的發揮、自身平台的構建等客觀情況的影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account